系统性红斑狼疮的诊断与管理
本文综述SLE诊断与管理的现状与挑战:早期诊断困难、检测特异性不足、疾病模式高度可变、 flares不可预测且不总与生物标志物相关;儿童与老年患者管理复杂;现有药物控制不足且长期使用有脱靶效应;但生物学进展已转化为更有效的诊疗策略。
要点
- SLE早期诊断困难,早期检测缺乏特异性,器官损伤后才出现有用检测。
- 疾病模式高度可变, flares不可预测且不总与生物标志物相关。
- 儿童SLE可能病情严重,老年SLE患者合并症复杂,需特殊管理。
核心结论
- 尽管SLE诊断与管理面临诸多挑战,对生物学基础的理解进展已转化为更有效的患者管理策略。
研究设计与样本
- 本文为综述,考虑SLE诊断与管理的当前状态,聚焦新方法和预期进展。
主要发现
- SLE起病可能隐匿,症状体征多样,使早期准确诊断具有挑战性。
- 早期SLE检测缺乏特异性,后期有用的检测常在器官损伤显现后才出现。
- SLE疾病模式高度可变, flares不可预测且不总与生物标志物相关。
- 儿童SLE可能病情严重并存在特殊管理问题,老年SLE患者有复杂合并症。
- 近几十年来治疗干预已改善,但现有药物不能充分控制许多患者疾病,且脱靶效应限制成功结局。
临床怎么用
- 临床需认识SLE早期诊断困难,检测特异性不足,避免依赖单一早期检测。
- 管理SLE应关注疾病模式可变性和 flares不可预测性,不总依赖生物标志物。
- 儿童和老年SLE患者需考虑特殊管理问题和合并症。
- 使用现有药物时需权衡长期脱靶效应,并关注生物学进展带来的新方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
SLE presents many challenges for clinicians. The onset of disease may be insidious, with many different symptoms and signs, making early and accurate diagnosis challenging. Tests for SLE in the early stages lack specificity; those that are useful later often appear only after organ damage is manifest. Disease patterns are highly variable; flares are not predictable and not always associated with biomarkers. Children with SLE may have severe disease and present special management issues. Older SLE patients have complicating co-morbid conditions. Therapeutic interventions have improved over recent decades, but available drugs do not adequately control disease in many patients, and successful outcomes are limited by off-target effects; some of these become manifest with longer duration of treatment, now in part revealed by improved rates of survival. Despite all of these challenges, advances in understanding the biological basis of SLE have translated into more effective approaches to patient care. This review considers the current state of SLE diagnosis and management, with a focus on new approaches and anticipated advances.
引用
- Thong B, Olsen NJ. Systemic lupus erythematosus diagnosis and management. Rheumatology (Oxford). 2017. PMID: 28013206. doi:10.1093/rheumatology/kew401
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。